Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
IgG receptor IIa alleles determine susceptibility and severity of Guillain-Barré syndrome.
van der Pol WL, van den Berg LH, Scheepers RH, van der Bom JG, van Doorn PA, van Koningsveld R, van den Broek MC, Wokke JH, van de Winkel JG. van der Pol WL, et al. Among authors: van den berg lh, van der bom jg, van doorn pa, van koningsveld r, van den broek mc, van de winkel jg. Neurology. 2000 Apr 25;54(8):1661-5. doi: 10.1212/wnl.54.8.1661. Neurology. 2000. PMID: 10762510 Clinical Trial.
Recurrent Guillain-Barré syndrome.
Kuitwaard K, van Koningsveld R, Ruts L, Jacobs BC, van Doorn PA. Kuitwaard K, et al. Among authors: van koningsveld r, van doorn pa. J Neurol Neurosurg Psychiatry. 2009 Jan;80(1):56-9. doi: 10.1136/jnnp.2008.156463. Epub 2008 Oct 17. J Neurol Neurosurg Psychiatry. 2009. PMID: 18931012
Immunotherapy for Guillain-Barré syndrome.
van Doorn PA, van Koningsveld R. van Doorn PA, et al. Among authors: van koningsveld r. Lancet Neurol. 2004 Feb;3(2):84. doi: 10.1016/s1474-4422(03)00660-4. Lancet Neurol. 2004. PMID: 14746999 Review. No abstract available.
43 results